Sugi Predict

Sugi Predict / Compounds / SCHEMBL793724

SCHEMBL793724

SCHEMBL793724

O=C(O)c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ NR4A2 P43354 2/20 0.57
▸ NR4A1 P22736 1/20 0.57
▸ NR4A3 Q92570 1/20 0.57
▸ RXRA P19793 3/20 0.54
▸ HPGD P15428 3/20 0.54
▸ RXRB P28702 2/20 0.54
▸ RXRG P48443 1/20 0.54
▸ MRGPRX4 Q96LA9 3/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ MITF O75030 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ XBP1 P17861 1/20 0.54
▸ NFKB1 P19838 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ NFKB2 Q00653 1/20 0.54
▸ RELA Q04206 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ PTGER1 P34995 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL514496 0.98 MEN1 (0.63) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL14660694 0.98 MEN1 (0.63) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL15673277 0.92 RXRA (0.62) MEN1KMT2ARXRAHPGDMRGPRX4
SCHEMBL2227072 0.91 LMNA (0.56) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL28236202 0.90 KDM4E (0.53) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL15369572 0.89 RXRA (0.58) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL17191962 0.89 MRGPRX4 (0.58) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL6659601 0.89 ATM (0.61) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL11762649 0.89 RXRA (0.61) MEN1KMT2ARXRAHPGDRXRB
SCHEMBL2317454 0.89 RXRA (0.61) MEN1KMT2ARXRAHPGDMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823126-B Leishmot galloyl derivative and synthesis method and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 — — CN claimed
CN-119823126-A Leishmot galloyl derivative and synthesis method and application thereof 沈阳药科大学 2025-04-15 — — CN claimed
CN-118420574-A Fluorescent probe, preparation method thereof and application thereof in metal ion identification 北京印刷学院 2024-08-02 — — CN claimed
CN-118359605-A Fluorescent probe, preparation method thereof and application thereof in cobalt ion detection 北京印刷学院 2024-07-19 — — CN claimed
CN-115212314-A Albumin-bound antitumor drug and nano-composite thereof, and preparation method and application thereof 沈阳药科大学 2022-10-21 — — CN claimed
CN-113105395-B 4-phenylsulfonyl-1-trihydroxy benzoyl piperazine-2-carboxamide derivative and preparation method and application thereof 山东大学 2022-06-17 — — CN claimed
CN-113105395-A 4-phenylsulfonyl-1-trihydroxy benzoyl piperazine-2-carboxamide derivative and preparation method and application thereof 山东大学 2021-07-13 — — CN claimed
CN-108440389-B 3,4, 5-trihydroxybenzoic acid derivative and preparation method and application thereof 山东大学 2020-05-29 — — CN claimed
EP-2616439-B1 TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY COUNCIL SCIENT IND RES (IN) 2015-12-16 — — EP claimed
US-8901317-B2 Tryptamine derivatives, their preparation and their use in gastropathy COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-02 — — US claimed
US-20130197052-A1 TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY UNIVERSITY OF CALCUTTA (IN) 2013-08-01 — — US claimed
EP-2616439-A1 TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY Council of Scientific & Industrial Research (IN) 2013-07-24 — — EP claimed
WO-2012035406-A1 TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-03-22 — — WO claimed
US-7126014-B2 Synthesis of epecatechin-4α, 8-epicatechin and -catechin dimers and derivatives thereof MARS, INC. 2006-10-24 — — US claimed
US-6476241-B1 Synthesis of 4α-arylepicatechins MARS INCORPORATED 2002-11-05 — — US claimed
CN-119823126-B Leishmot galloyl derivative and synthesis method and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 — — CN disclosed
US-12473264-B2 Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof PURDUE RESEARCH FOUNDATION (US) 2025-11-18 — — US disclosed
WO-2001036436-A1 GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2001-05-25 — — WO disclosed
US-6156912-A 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation MARS, INCORPORATED (US) 2000-12-05 — — US disclosed
WO-2000061547-A1 8-8, 6-6 AND 6-8 CATECHIN AND EPICATECHIN DIMERS AND METHODS FOR THEIR PREPARATION MARS, INCORPORATED (US) 2000-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473264-B2 Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof HBG1, SPTBN1, CTTN MEN1 3661/4885KMT2A 3266/4885NR4A2 4202/4885
US-20130197052-A1 TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY HTRA2, AIFM1, SI MEN1 3990/4885KMT2A 3725/4885NR4A2 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.